News

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
Find out which vaccines are recommended while you're pregnant to protect you and your baby, and which you'll need to wait on.
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...
In June, infectious disease physicians sounded the alarm over the Trump administration overstepping existing, transparent processes for changing vaccine recommendations, particularly pointing to new ...
“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...
Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...
A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.
A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...
FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...
GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...